Clinical Trial Update: Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating aminolevulinic acid during surgery for malignant brain tumors; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Brain Tumor
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: University of Washington | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Status: TERMINATED